AU5891394A - A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration - Google Patents
A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regenerationInfo
- Publication number
- AU5891394A AU5891394A AU58913/94A AU5891394A AU5891394A AU 5891394 A AU5891394 A AU 5891394A AU 58913/94 A AU58913/94 A AU 58913/94A AU 5891394 A AU5891394 A AU 5891394A AU 5891394 A AU5891394 A AU 5891394A
- Authority
- AU
- Australia
- Prior art keywords
- neurotrophin
- neurite growth
- antibody
- myelin
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1635493A | 1993-02-11 | 1993-02-11 | |
| US016354 | 1993-02-11 | ||
| PCT/IB1994/000011 WO1994017831A1 (en) | 1993-02-11 | 1994-02-08 | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5891394A true AU5891394A (en) | 1994-08-29 |
Family
ID=21776697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU58913/94A Abandoned AU5891394A (en) | 1993-02-11 | 1994-02-08 | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0634939A1 (xx) |
| JP (1) | JPH07509002A (xx) |
| AU (1) | AU5891394A (xx) |
| CA (1) | CA2117889A1 (xx) |
| IL (1) | IL108600A0 (xx) |
| WO (1) | WO1994017831A1 (xx) |
| ZA (1) | ZA94887B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6576441B1 (en) | 1995-12-06 | 2003-06-10 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin Z and gene encoding the same |
| WO1998011216A1 (fr) | 1996-09-11 | 1998-03-19 | Sumitomo Pharmaceuticals Company, Limited | Nouveau gene de semaphorine: semaphorine y |
| US6902730B1 (en) | 1996-10-09 | 2005-06-07 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin gene: Semaphorin W |
| CA2190418A1 (en) * | 1996-11-15 | 1998-05-15 | Zhi-Cheng Xiao | Neuron and neural tumor growth regulatory system, antibodies thereto and uses thereof |
| AU4964097A (en) | 1996-11-15 | 1998-06-10 | Sumitomo Pharmaceuticals Company, Limited | Novel semaphorin genes (i) |
| EP0878480A1 (en) * | 1997-05-14 | 1998-11-18 | H.W. Prof. Dr. Müller | A method for the improvement of neuronal regeneration |
| SE9901428D0 (sv) * | 1999-04-21 | 1999-04-21 | Karolinska Innovations Ab | Amphibodies |
| AU784349C (en) | 2000-01-12 | 2006-09-28 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| NZ525422A (en) | 2000-10-06 | 2006-09-29 | Biogen Idec Inc | Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons |
| CA2549000A1 (en) * | 2003-12-16 | 2005-06-30 | Children's Medical Center Corporation | Method for treating neurological disorders |
| US8912144B2 (en) | 2003-12-16 | 2014-12-16 | Children's Medical Center Corporation | Method for treating stroke via administration of NEP1-40 and inosine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100196540B1 (ko) * | 1988-11-04 | 1999-06-15 | 마틴 이. 샤브 | 축색성장 조절인자 |
| GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
| WO1993000427A2 (en) * | 1991-06-24 | 1993-01-07 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
| JP2008027291A (ja) * | 2006-07-24 | 2008-02-07 | Hitachi Ltd | ストレージ装置及びデータ保護方法 |
-
1994
- 1994-02-08 AU AU58913/94A patent/AU5891394A/en not_active Abandoned
- 1994-02-08 EP EP94905206A patent/EP0634939A1/en not_active Withdrawn
- 1994-02-08 CA CA002117889A patent/CA2117889A1/en not_active Abandoned
- 1994-02-08 WO PCT/IB1994/000011 patent/WO1994017831A1/en not_active Application Discontinuation
- 1994-02-08 JP JP6517851A patent/JPH07509002A/ja active Pending
- 1994-02-09 IL IL10860094A patent/IL108600A0/xx unknown
- 1994-02-09 ZA ZA94887A patent/ZA94887B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA94887B (en) | 1994-08-23 |
| JPH07509002A (ja) | 1995-10-05 |
| IL108600A0 (en) | 1994-05-30 |
| CA2117889A1 (en) | 1994-08-18 |
| EP0634939A1 (en) | 1995-01-25 |
| WO1994017831A1 (en) | 1994-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6291247B1 (en) | Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity | |
| US10100100B2 (en) | Metallothionein-derived peptide fragments | |
| US8008259B2 (en) | Neurotrophin-derived peptide sequences | |
| US9044428B2 (en) | Neuritogenic peptides | |
| JP2006087434A (ja) | 新規な神経栄養因子 | |
| JP4638027B2 (ja) | ヘパリン結合増殖因子（ｈｂｇｆ）ポリペプチド | |
| CA2129423A1 (en) | Hepatic growth factor receptor | |
| EP1124960A2 (en) | Activity dependent neurotrophic factor iii (adnf iii) | |
| WO1998022499A9 (en) | Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof | |
| WO1998022499A2 (en) | Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof | |
| JPH07506488A (ja) | ｎｅｕレセプターの組換え刺激因子 | |
| AU5891394A (en) | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration | |
| BRPI0614419A2 (pt) | peptìdeos derivados de gdnf | |
| CA2279231C (en) | Activity dependent neurotrophic factor iii (adnf iii) | |
| WO1994017831A9 (en) | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration | |
| JPH08500246A (ja) | 細胞増殖の阻害剤，その調製および用途 | |
| US5504197A (en) | DNA encoding neurotrophic growth factors | |
| Sottile et al. | Assembly of fibronectin molecules with mutations or deletions of the carboxyl-terminal type I modules | |
| WO2007071248A2 (en) | Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins | |
| EP2140000A1 (en) | Method of enhancing migration of neural precursor cells | |
| EP0753013A1 (en) | Neurotrophin-6: a new member of the neurotrophin family | |
| CA2221391A1 (en) | Neuron and neural tumour growth regulatory system, antibodies thereto and uses thereof | |
| MXPA00001234A (en) | Heparin-binding growth factor (hbgf) polypeptides | |
| JPH05506659A (ja) | エピテリン類：新規なシステインに富む成長変調タンパク | |
| WO2011135304A1 (en) | Ncam-vase and neuroregeneration |